Financial Highlights
See the financial overview of Kyobo Life
Total Assets
(Unit: KRW billion)
- IFRS4 FY2020 : 115,486.1
- IFRS4 FY2021 : 119,149.3
- IFRS4 FY2022 : 117,175.7
- IFRS17 FY2022 : 107,826.6
- IFRS17 FY2023 : 115,079.6
Total Equity
(Unit: KRW billion)
- IFRS4 FY2020 : 10,997.2
- IFRS4 FY2021 : 11,024.0
- IFRS4 FY2022 : 5,909.7
- IFRS17 FY2022 : 12,715.6
- IFRS17 FY2023 : 9,762.4
Premium Income
(Unit: KRW billion)
- IFRS4 FY2020 : General Account 8,836.6 + Separate Account 5,443.4 = 14,280.0
- IFRS4 FY2021 : General Account 9,560.7 + Separate Account 6,247.6 = 15.808.3
- IFRS4 FY2022 : General Account 12,658.4 + Separate Account 8,077.7 = 20,736.1
- IFRS17 FY2022 : 20,736.1
- IFRS17 FY2023 : 18,987.0
- Separate Account
- General Account
Net Income
(Unit: KRW billion)
- IFRS4 FY2020 : 382.9
- IFRS4 FY2021 : 396.4
- IFRS4 FY2022 : 395.2
- IFRS17 FY2022 : 429.8
- IFRS17 FY2023 : 489.1
- IFRS4 FY2020 : 0.3
- IFRS4 FY2021 : 0.3
- IFRS4 FY2022 : 0.3
- IFRS17 FY2022 : 0.4
- IFRS17 FY2023 : 0.4
ROA = Net Income / {(Beginning Total Assets + Ending Total Assets) / 2}
- IFRS4 FY2020 : 3.5
- IFRS4 FY2021 : 3.6
- IFRS4 FY2022 : 4.7
- IFRS17 FY2022 : 3.8
- IFRS17 FY2023 : 4.4
ROE = Net Income / {(Beginning Total Capital + Ending Total Capital) / 2}
Return on Investment
(Unit : %)
- FY2019 : 3.9
- FY2020 : 3.6
- FY2021 : 3.6
- FY2022 : 3.4
- FY2023 : 3.4
Return on Investment = (Investment Income – Insurance Finance Income – Variable Insurance Hedge Income) / {(Beginning Operating Assets + Ending Operating Assets) /2}
- FY2022 : before : 180.6
- 1Q FY2023 : before : 156.0 after :232.4
- 2Q FY2023 : before : 179.6 after :269.4
- 3Q FY2023 : before : 183.2 after :183.2
- The RBC ratio for 2022, and the K-ICS ratio for 2023
- Solvency Ratio = Solvency Margin / Total K-ICS risk or RBC risk
- Based on Consolidated Financial Statements